Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 8Neoplasm Metastasis 7Multiple Myeloma 6Prostatic Neoplasms 5Pain 3Uterine Cervical Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Bone Neoplasms 2Uterine Cervical Dysplasia 1Urologic Neoplasms 1Small Cell Lung Carcinoma 1Precancerous Conditions 1Pleural Effusion, Malignant 1Osteoporosis 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Lung Neoplasms 1Kidney Neoplasms 1Humoral Hypercalcemia Of Malignancy 1Hematologic Neoplasms 1Giant Cell Tumors of Bone 1Giant Cell Tumor of Bone 1Disease Progression 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Cyclophosphamide 14fludarabine 10fludarabine phosphate 8Whole-Body Irradiation 7thymoglobulin 5Thiotepa 5Tacrolimus 5Stem Cell Transplantation 5Nivolumab 5Granulocyte Colony-Stimulating Factor 5Busulfan 5Azacitidine 5venetoclax 4Standard of Care 4Radiotherapy 4Practice Guidelines as Topic 4Mycophenolic Acid 4Methotrexate 4Melphalan 4Filgrastim 4Cytarabine 4Antilymphocyte Serum 4Rituximab 3Mesna 3Leucovorin 3Dexamethasone 3Calcium Dobesilate 3Alemtuzumab 3ruxolitinib 2ceritinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hematologic Neoplasms × Zoledronic Acid × Clear all
NCT00215943 2014-04-17

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

H. Lee Moffitt Cancer Center and Research Institute

Phase 3 Terminated
90 enrolled 10 charts
Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡